Ketamine Korner: Edition 2
Ketamine Korner is a bi-weekly newsletter exploring advances in ketamine therapy, originally started by Mind Pain Relief Institute Co-Founder Dr. Rohit Aiyer.
Each edition is republished with permission from Dr. Aiyer.
Latest Research:
Research Update: A recent clinical trial published in June 2025 (the MUSIK trial) suggests that pairing ketamine with a structured therapeutic environment can produce more durable relief in severe depression. In this study, patients who experienced more intense subjective (psychedelic-like) effects during infusion showed stronger and longer lasting symptom improvement. The results reinforce the importance of context, integration, and psychotherapy alongside ketamine use.
A Brief History of Ketamine in Mental Health:
Psychotherapy Integration: Early experiments in the 1970s paired ketamine infusion with talk therapy, hinting at a combined pharmacologic + psychological route. Over the decades, this combined model was overshadowed by mechanistic research until recently.
Montreal Model & Modern Revival: The MUSIK trial builds on the “Montreal Model” of ketamine-assisted psychotherapy, which emphasizes set, setting, emotional support, and integration. Clinics and researchers are increasingly endorsing these structured models as best practice.
Evolving Acceptance: As scientific evidence and regulatory frameworks mature (e.g. expanded approvals for esketamine), the view of ketamine is shifting: from fringe treatment to a carefully managed, integrated clinical tool.
Mythbuster:
Myth: Ketamine’s effect depends only on the drug and dosage, not the environment.
Reality: The latest data suggest otherwise. In the MUSIK trial, patients who had more intense subjective experiences during ketamine infusions (e.g. more dissociation or altered states) tended to show stronger, more lasting improvements — only when these experiences were actively guided in a therapeutic context.
This underlines that ketamine is not a “magic bullet” — how it’s delivered, the psychological support, and the integration matter significantly.
As the science evolves, so does our understanding of ketamine’s place in modern psychiatry. Staying informed helps us separate fact from myth and see where the future of treatment may lead.
Until next time, stay curious and engaged with the possibilities ahead.